GSK: Q4 turnover increases 9% to £9.5B

Wednesday, 09. February 2022 08:15

GlaxoSmithKline plc (GSK) announced on Wednesday that its turnover rose 9% year on year to reach £9.5 billion in the fourth quarter of fiscal 2021.

Total operating profit fell 16% to £895 million in the closing trimester, while total earnings per share came in at 15 pence, increasing 10% from the same time span the year prior.

Full-year turnover stood at 34.1 £billion in 2021, stable from 2020. Total operating profit dropped 20% to £6.2 billion and total earnings per share declined 24% from the previous year to 87.6 pence in 2021.

Related Links: GlaxoSmithKline PLC
Baha Breaking News (BBN) / MS